Merck KGaA appoints Oschmann as CEO to replace Kley

Germany's Merck KGaA said it would promote its deputy chief executive, Stefan Oschmann, to the top job in April next year to replace Karl-Ludwig Kley, who will retire.Reuters | Updated: October 14, 2015, 08:56 IST

Oschmann will take over as chief executive after the group's annual shareholder meeting on April 29, 2016, the German drugs and chemicals maker said in a statement on Tuesday.

Kley's current contract would have expired in September 2016.

Oschmann, previously the head of its pharma business, became deputy chief executive at the beginning of this year.

Before joining Merck KGaA in 2011, German-born Oschmann was in charge of Merck & Co Inc's emerging markets operations. The two companies share historic roots but are under separate ownership since World War One.(Reporting by Ludwig Burger; Editing by Arno Schuetze)

With immense pride “India Live” celebrated its 10th national conference in Mumbai from 28th February to 3rd March 2019. The conference turned out to be a gold mine of information, with emphasis on academics, education and exchange of knowledge with leaders in interventional cardiology from both India and abroad.